Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Pace, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pace, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Use of nonsteroidal anti-inflammatory drugs in cancer

Victor Pace

St Christopher's Hospice, London

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in cancer, yet they are also responsible for many, often serious, adverse effects. This review examines the various mechanisms through which NSAIDs work. It looks at the experience built up in using NSAIDs in cancer pain in general, but then particularly examines whether the evidence available supports the claim often made that these drugs have a specific role in relief of pain from bony metastases. Criteria for choosing one NSAID over another, including adverse effect profiles, efficacy and tolerability, are considered, as are methods for improving the safe use of these drugs.

Key Words: anti-inflammatory agents • nonsteroidal • bone neoplasms • secondary • drug toxicity (non-MeSH) • pain • palliative treatment

Palliative Medicine, Vol. 9, No. 4, 273-286 (1995)
DOI: 10.1177/026921639500900402
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Palliat MedHome page
S. Human
Prophylactic gastroprotection for palliative care patients taking NSAIDs: an audit
Palliative Medicine, December 1, 2004; 18(8): 738 - 738.
[PDF]

Home page
 Palliat MedHome page
A. Dickman and J. Ellershaw
For Discussion NSAIDs: gastroprotection or selective COX-2 inhibitor?
Palliative Medicine, June 1, 2004; 18(4): 275 - 286.
[Abstract] [PDF]

Home page
 AM J HOSP PALLIAT CAREHome page
J. Varga and A. Dickman
Ibuprofen to rofecoxib: What does it all mean and what do I do now?
American Journal of Hospice and Palliative Medicine, July 1, 2001; 18(4): 271 - 274.
[Abstract] [PDF]

Home page
 Palliat MedHome page
C. A Jenkins and E. Bruera
Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients
Palliative Medicine, April 1, 1999; 13(3): 183 - 196.
[Abstract] [PDF]